- Home
- PDX vs IART Comparison
PDX vs IART Comparison
Compare PDX & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDX
- IART
- Stock Information
- Founded
- PDX 2019
- IART 1989
- Country
- PDX NY
- IART United States
- Employees
- PDX N/A
- IART N/A
- Industry
- PDX Finance/Investors Services
- IART Medical/Dental Instruments
- Sector
- PDX Finance
- IART Health Care
- Exchange
- PDX Nasdaq
- IART Nasdaq
- Market Cap
- PDX 1.1B
- IART 978.4M
- IPO Year
- PDX N/A
- IART 1995
- Fundamental
- Price
- PDX $24.58
- IART $12.31
- Analyst Decision
- PDX
- IART Hold
- Analyst Count
- PDX 0
- IART 8
- Target Price
- PDX N/A
- IART $18.17
- AVG Volume (30 Days)
- PDX N/A
- IART 1.1M
- Earning Date
- PDX 01-01-0001
- IART 07-31-2025
- Dividend Yield
- PDX 4.95%
- IART N/A
- EPS Growth
- PDX N/A
- IART N/A
- EPS
- PDX N/A
- IART N/A
- Revenue
- PDX N/A
- IART $1,621,738,000.00
- Revenue This Year
- PDX N/A
- IART $5.56
- Revenue Next Year
- PDX N/A
- IART $4.41
- P/E Ratio
- PDX N/A
- IART N/A
- Revenue Growth
- PDX N/A
- IART 3.53
- 52 Week Low
- PDX $13.52
- IART $11.06
- 52 Week High
- PDX $21.05
- IART $27.13
- Technical
- Relative Strength Index (RSI)
- PDX 50.98
- IART 47.35
- Support Level
- PDX $24.08
- IART $12.27
- Resistance Level
- PDX $24.88
- IART $14.07
- Average True Range (ATR)
- PDX 0.45
- IART 0.66
- MACD
- PDX -0.03
- IART 0.07
- Stochastic Oscillator
- PDX 41.32
- IART 41.14
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.